Eudaimonia Partners’s iShares Biotechnology ETF IBB Stock Holding History

Eudaimonia Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$219K	Buy	1,352 +61	+5%	+$10.3K	0.04%	354
2021 Q2	$211K	Buy	1,291 +72	+6%	+$11.1K	0.04%	364
2021 Q1	$184K	Buy	1,219 +42	+4%	+$6.67K	0.04%	347
2020 Q4	$178K	Buy	1,177 +155	+15%	+$22.2K	0.04%	330
2020 Q3	$138K	Hold	1,022	–	–	0.04%	339
2020 Q2	$140K	Sell	1,022 -52	-5%	-$6.63K	0.05%	288
2020 Q1	$116K	Hold	1,074	–	–	0.05%	304
2019 Q4	$129K	Buy	+1,074	New	+$120K	0.05%	307

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Eudaimonia Partners's IBB Position: Q3 2021 in Review

Eudaimonia Partners increased its iShares Biotechnology ETF (IBB) stake by 4.7% in Q3 2021, buying an estimated $10.3K and bringing the position to 1,352 shares worth $219K. The position accounts for 0.04% of the portfolio, ranked #354.

Eudaimonia Partners first reported a position in IBB in Q4 2019 and has held it in 8 quarters since. 855 funds tracked by Wall St. Rank hold IBB as of Q3 2021.

Eudaimonia Partners held 1,352 shares of iShares Biotechnology ETF worth $219K as of Q3 2021.
Eudaimonia Partners bought 61 iShares Biotechnology ETF shares in Q3 2021, an estimated $10.3K.
iShares Biotechnology ETF made up 0.04% of Eudaimonia Partners's portfolio in Q3 2021, its #354 holding.
Eudaimonia Partners first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 8 quarters since.
855 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2021.

Based on Eudaimonia Partners's 13F filing for Q3 2021, filed 25 Oct 2021.